Human mesenchymal stem cells (hMSCs), during in vitro expansion, gradually lose their distinct spindle morphology, self-renewal ability, multi-lineage differentiation potential and enter replicative senescence. This loss of cellular function is a major roadblock for clinical applications which demand cells in large numbers. Here, we demonstrate a novel role of substrate stiffness in the maintenance of hMSCs over long-term expansion. When serially passaged for 45 days from passage 3 to passage 18 on polyacrylamide gel of Young9s modulus E=5 kPa, hMSCs maintained their proliferation rate and showed nine times higher population doubling in comparison to their counterparts cultured on plastic Petri-plates. They did not express markers of senescence, maintained their morphology and other mechanical properties such as cell stiffness and cellular traction, and were significantly superior in adipogenic differentiation potential. These results were demonstrated in hMSCs from two different sources, umbilical cord and bone marrow. In summary, our result shows that a soft gel is a suitable substrate to maintain the stemness of mesenchymal stem cells. As preparation of polyacrylamide gel is a well-established, and well-standardized protocol, we propose that this novel system of cell expansion will be useful in therapeutic and research applications of hMSCs.
Recent studies have shown that mechanical properties such as extracellular matrix stiffness, fluid flow, weight loading, compression, and stretching can affect cellular functions. Some examples of cell responses to mechanical properties could be the migration of cancer cells from rigid to soft surfaces or the differentiation of fibroblasts into myofibroblasts. Cellular responses to mechanical changes can modify the insertion of proteins in the extracellular matrix (ECM), causing an increase in tissue stiffness with functional consequences. In general, mechanical and physical factors can affect any kind of cell phenotype in culture conditions and in vivo tissues. Cells sense mechanical stimuli by applying force and restructuring their shape and functions in response to the resistance of the stimuli. Furthermore, mechanical triggers can develop a “memory” for altering cellular plasticity and adaptation. This phenomenon is called cellular mechanical memory (CMM), a singular feature of mesenchymal stem cells (MSCs). Controlled targeting of CMM may resolve the scarcity of viable cells needed for cell based therapy (CBT) and implement studies concerning cancer research, fibrosis, and senescence. This review focusses on cells from the mesodermal lineage, such as MSCs, fibroblasts and chondrocytes, and the role of CMM as a potential target for CBT.
The presence of senescent cells causes age‐related pathologies since their removal by genetic or pharmacological means, as well as possibly by exercise, improves outcomes in animal models. An alternative to depleting such cells would be to rejuvenate them to promote their return to a replicative state. Here we report that treatment of non‐growing senescent cells with low‐frequency ultrasound (LFU) rejuvenates the cells for growth. Notably, there are 15 characteristics of senescent cells that are reversed by LFU, including senescence‐associated secretory phenotype (SASP) plus decreased cell and organelle motility. There is also inhibition of β‐galactosidase, p21, and p16 expression, telomere length is increased, while nuclear 5mC, H3K9me3, γH2AX, nuclear p53, ROS, and mitoSox levels are all restored to normal levels. Mechanistically, LFU causes Ca 2+ entry and increased actin dynamics that precede dramatic increases in autophagy and an inhibition of mTORC1 signaling plus movement of Sirtuin1 from the nucleus to the cytoplasm. Repeated LFU treatments enable the expansion of primary cells and stem cells beyond normal replicative limits without altering phenotype. The rejuvenation process is enhanced by co‐treatment with cytochalasin D, rapamycin, or Rho kinase inhibition but is inhibited by blocking Sirtuin1 or Piezo1 activity. Optimized LFU treatment parameters increased mouse lifespan and healthspan. These results indicate that mechanically induced pressure waves alone can reverse senescence and aging effects at the cellular and organismal level, providing a non‐pharmacological way to treat the effects of aging.
Traumatic brain injury (TBI), caused by falls and blast exposure, rapidly deforms and stretches brain tissue, including the hippocampus, which is involved in memory formation and spatial learning. Mechanical forces are generated within milliseconds of injury; however, long-term consequences suggest that injury induces persistent alterations in the hippocampus. Advances in mechanobiology have revealed that cells remember past mechanical experience, called “mechanical memory,” in which prior mechanical experiences continue to influence cellular behavior even after the original stimulus is removed. In this chapter, we propose that TBI may induce mechanical memory in hippocampal cells through both the initial mechanical insult and subsequent secondary changes in the hippocampus such as altered tissue stiffness, shear, compression, and extracellular matrix (ECM) remodeling. We hypothesize that this mechanical memory contributes to the persistence of cellular dysfunction, including neuroinflammation, cellular senescence, impaired neurogenesis, resulting in progressive cognitive and memory deficits. Although direct evidence linking TBI to mechanical memory is currently lacking, mechanotransduction pathways are known to be activated during brain injury, and epigenetic alterations, a key mechanism of mechanical memory, are well documented after TBI. We review existing evidence on mechanical forces in the hippocampus and explore whether targeting mechanical memory could represent a novel therapeutic strategy for mitigating the long-term neurological consequences of TBI.